diabetes
Conditions
Interventions
Experimental Group:Continuous glucose monitoring system monitoring
Sponsors
The Second Affiliated Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with diabetes mellitus, aged 18 years and above, gender is not limited, and vital signs are stable. 2. Those who can establish venous blood collection access in the forearm. 3. Hematocrit/crit <=70%. 4. Voluntarily participate in this trial and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1. Those who have damaged, scarred, red, swollen or infected skin on the upper arm. 2. Those who are allergic to alcohol disinfectants or medical adhesive tapes. 3. Those with severe bleeding tendency or abnormal coagulation function (APTT= upper limit of normal value 1.5 times) during the screening period. 4. Pregnant or lactating women, and those who plan to become pregnant during the test. 5. Have epilepsy or cognitive impairment. 6. Patients with subcutaneous edema at the wearing site. 7. Those who plan to undergo magnetic magnetic imaging (MRI), computed tomography (CT) or X-ray examination within 15 days of wearing. 8. Those who have participated in other interventional device clinical trials or participated in drug clinical trials within 5 half-lives of the last drug within 1 month before the start of this trial. 9. Those who are considered by the investigator to be inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consistency within the error range compared with the reference values of the control group; ; | — |
Countries
China
Contacts
Public ContactLuyibing
The Second Affiliated Hospital of Nanjing Medical University
Outcome results
None listed